Biocon Biologics Walk In 24th July 2022 for Bsc,Msc,B.pharma,M.pharma,Btech,Mtech Freshers & Experienced

 Biocon Biologics India Limited Walk In Interview  2022  B.Sc / BE / B.Tech / B.Pharma / M.Sc / ME / M.Tech / M.Pharma or Ph.D for QA/QC/RND/Biosimilars Manufacturing/QMS/Process Engineering/MSAT/RA/SCM/Support Function At Hyderabad . Biocon Biologics India Limited Notification full details below..Interested and eligible candidates can attend interview on scheduled time and venue.

Vacancy details:

  • Post Name: QA/QC/RND/Biosimilars Manufacturing/QMS/Process Engineering/MSAT/RA/SCM/Support Function
  • Qualification: B.Sc / BE / B.Tech / B.Pharma / M.Sc / ME / M.Tech / M.Pharma or Ph.D  
  • Experienced:0 to 5 years

Job Description: Biocon Biologics India Limited Hiring For QA/QC/RND/Biosimilars Manufacturing/QMS/Process Engineering/MSAT/RA/SCM/Support Function !

Important Details :

  • Location: Hyderabad
  • Walk In Date :July 24th, 2022 (Sunday)
  • Time: 9:00 am to 12:00 pm
  • venue:Biocon Biologics India Limited Biocon House, Tower-3, Semicon Park Electronic City, Phase II, Hosur Road Bengaluru, Karnataka, 560100
  • Note:Interested candidates may send their resumes or queries to
  • Post of date:12/07/2022
  • Selection Process: The selection will be on the basis of Interview.

Job description.

Desired Experience:

• Quality Assurance

• Quality Control (Bioassay, Analytical & Microbiology) • RND (Process Science & Analytical Science)

Biosimilars Manufacturing (Upstream & Downstream)

QMS Manufacturing

• Process Engineering (Upstream & Downstream) Fill Finish Manufacturing (Asceptic Manufacturing, DP Medical Device & DP Packaging)

MSAT (Biosimilars, Drug Product & Insulin)

• Insulin Manufacturing Regulatory Affairs

SCM (Warehouse, Procurement & Sourcing)

Support Functions (IT, Finance & Legal)

About Company:

We are certified as amongst India’s Best Workplaces in Diversity, Equity & Inclusion (DEI) by Great Place to Work, and with strong sense of purpose & commitment toward DEI, we aim to be a gender-neutral organization by 2030. As a result, we are investing in building the next cadre of empathetic and smart women leaders who will shape and transform the business further.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *